Top Markets
Coin of the day
Epigenomics AG Epigenomics AG

Epigenomics AG

ECX
주식 순위 #38936
Founded in 1998 and headquartered in Berlin, Germany, Epigenomics AG is a... Founded in 1998 and headquartered in Berlin, Germany, Epigenomics AG is a molecular diagnostics company dedicated to the early detection of cancer through liquid biopsy methods. Its primary offering, Epi proColon, is a blood-based assay specifically developed for the early identification of colorectal cancer, distributed across the United States, Europe, and China. The company's portfolio further encompasses a blood test for hepatocellular carcinoma and Epi BiSKit, a pre-analytical solution providing reagents essential for preparing bisulfite-converted DNA. Epigenomics' research and development initiatives are focused on pinpointing relevant biomarkers in human tissue and subsequently creating and securing patents for associated in vitro diagnostic blood tests.
주가
$0.83030862
마지막 동기화: 2024-06-27
시가총액
$726.64K
변동 (1일)
-1.35%
변동 (1년)
0.00%
국가
DE
거래 Epigenomics AG (ECX)

카테고리

Epigenomics AG (ECX)의 주가 이력
최고 종가: $1.42 (2024-06-01 기준)

최저 종가: $761.72 (2014-09-01 기준)
Epigenomics AG의 주가 이력 (2014 ~ 2026)
연간 주가 성과
연도 성과
2024 -40.31%
2023 -70.25%
2022 -39.44%
2021 -83.30%
2020 -68.68%
2019 -24.83%
2018 -54.25%
2017 -3.39%
2016 90.76%
2015 -58.46%
2014 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$592.67 22.19%
US
$203.74 -3.08%
US
$23.08 67.91%
CN
$309.55 95.37%
US
$561.65 -14.11%
US